Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03832192 · ClinicalTrials.gov registry record · Phase 2
Care.Coach Avatars for Improvement of Outcomes in Hospitalized Elders, Including Mitigation of Falls and Delirium: a Multi-Site Clinical Study
A Phase 2 study of Delirium and Fall Injury, sponsored by Victor Wang.
- Completed
- Registry status
- Phase 2
- Development phase
- 301
- Enrollment target
- 1
- Study location
NCT03832192 is a Phase 2 study of Delirium and Fall Injury that has completed, run by Victor Wang. The registered enrollment target is 301 participants, below the 883-participant average among 62 other Delirium trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03832192, a Phase 2 study of Delirium and Fall Injury, has completed, sponsored by Victor Wang.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 301 participants
- Enrollment target
- 1
- Study location
Study Summary
Through NINR project 1R44NR017842-01 which preceded the present study, the investigators enhanced the care.coach avatar platform to incorporate a robust suite of evidence-based protocols based on the Hospital Elder Life Program (HELP), and to leverage an integration with hospital-based electronic medical record (EMR) systems. In the present study, the investigators seek to validate the efficacy of the new avatar platform, as measured by reduction in falls, delirium, and patient sitter utilization. Also, the investigators seek to gather patient and outcomes data at a scale sufficient to begin developing machine learning algorithms for intelligent, automatic assignment of protocols to maximize patient engagement and clinical efficacy, and for intelligent, automatic screening of delirium to assist care teams in positive identification of delirium. Therefore, the present study comprises a two-year randomized between-groups comparison across multiple hospitals to compare outcomes with the new generation of care.coach avatars as the intervention versus usual care only as the control. Each study group will be geographically distributed across participating research sites: initially MediSys Health Network's Jamaica Hospital Medical Center in New York, with additional hospitals to join the study over the course of two years.
Conditions Studied
Interventions
- BEHAVIORAL care.coach Avatar (HELP-Protocolized)
Study Locations (1)
New York
- Jamaica Hospital Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 301 participants |
| Start Date | 2019-01-08 |
| Est. Completion | 2021-01-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03832192
The ClinicalTrials.gov registry entry for NCT03832192 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 301 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 883-participant average among 62 other Delirium trials with a reported enrollment target (66% lower). The listed sponsor is Victor Wang, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Delirium appearing as the primary indexed condition, and to 1 intervention - of which care.coach Avatar (HELP-Protocolized) is the first listed.
NCT03832192 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03832192 about?
NCT03832192 is a clinical study titled "Care.Coach Avatars for Improvement of Outcomes in Hospitalized Elders, Including Mitigation of Falls and Delirium: a Multi-Site Clinical Study". Through NINR project 1R44NR017842-01 which preceded the present study, the investigators enhanced the care.coach avatar platform to incorporate a robust suite of evidence-based protocols based on the Hospital Elder Life Program (HELP), and to leverage an integration with hospital-based electronic me...
What is the current status of trial NCT03832192?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 301 participants. The study started on 2019-01-08. Estimated completion is 2021-01-07.
What conditions does trial NCT03832192 study?
This clinical trial studies the following conditions: Delirium, Fall Injury.
What interventions are being tested in trial NCT03832192?
The interventions under investigation include: care.coach Avatar (HELP-Protocolized) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03832192?
This trial is sponsored by Victor Wang, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03832192 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Delirium
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy
RECRUITING · Phase 2
-
Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care
ACTIVE NOT RECRUITING · Phase 2
-
Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer
ACTIVE NOT RECRUITING · Phase 2
-
High Dose Intravenous Thiamine for the Prevention of Delirium in Allogeneic Hematopoietic Stem Cell Transplantation
COMPLETED · Phase 2
-
Investigation of Sleep in the Intensive Care Unit
COMPLETED · Phase 2
-
The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.